Clinical Nutrition Market Size & Share, by Product (Infant Nutrition, Parenteral Nutrition, Enteral Nutrition); Application (Malnutrition, Cancer, Metabolic Disorder, Gastrointestinal Diseases, Neurological Diseases); End-User (Paediatric, Adults, Geriatric) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 6150
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Clinical Nutrition Market size was over USD 30.82 billion in 2023 and is projected to exceed USD 61.06 billion by the end of 2036, growing at over 5.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of clinical nutrition is evaluated at USD 32.15 billion.

The increasing prevalence of metabolic disorders globally, along with the growing investment in the healthcare expenditure are expected to fuel the development of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and rising middle-class population in emerging economies on a global level. According to the data collected from the United Nations Department of Economic and Social Affairs, in 2020, the estimated elderly population aged above 65 accounted for 727 million and by 2050 the number is expected to get double to approximately 1,500 million.


Clinical Nutrition Market Overview
Get more information on this report: Request Free Sample PDF

Clinical Nutrition Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Prevalence of Metabolic Disorders
  • Increasing Geriatric Population in the World

Challenges

  • Stringent Government Regulations
  • Lack of Awareness in the Under-Developed and Developing Countries

Clinical Nutrition Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.4%

Base Year Market Size (2023)

USD 30.82 billion

Forecast Year Market Size (2036)

USD 61.06 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Clinical Nutrition Segmentation

The market is segmented based on product into infant nutrition, parenteral nutrition, and enteral nutrition, out of which, the infant nutrition segment is anticipated to grab the largest share by the end of 2029 on account of increased number of malnourished babies and growing premature births. Moreover, increasing government approval of new infant nutrition products globally is also projected to contribute to the growth of the segment during the forecast period.

On the basis of application, the cancer segment in the global clinical nutrition market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that cancer patients are suffering from nutritional deficiency that arises due to various cancer treatments including radiation therapy, chemotherapy, stem cell transplant, and others. As a result, a considerable portion of the population with cancer on a global level is expected to drive the growth of the market over the forecast period. 

Based on end-user, the paediatric segment holds the largest share in the global clinical nutrition market on the back of growing concerns and awareness for malnutrition.

Our in-depth analysis of the global market includes the following segments

By Products

  • Infant Nutrition
    • Milk-based
    • Soy-based
    • Probiotic/Prebiotic
    • Others
  • Parenteral Nutrition
    • Amino Acids
    • Fats
    • Additives
    • Dextrose
  • Enteral Nutrition
    • Standard Composition
    • Disease specific Composition

By Application

  • Malnutrition
  • Cancer
  • Metabolic Disorder
  • Gastrointestinal Diseases
  • Neurological Diseases
  • Others

By End-User

  • Pediatric
  • Adults
  • Geriatric

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Clinical Nutrition Industry - Regional Synopsis

APAC Market Statistics

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific industry is estimated to dominate majority revenue share by 2036, owing to increasing birth rates, and rising geriatric population in the region.

North America Market Analysis

Furthermore, the market in North America is evaluated to occupy the largest share in terms of revenue during the forecast period, owing to the growing healthcare investment, accompanied by the presence of leading healthcare service providers, and the increasing number of chronic disorders in the region. Along with this, the countries in North America, such as the United States, are promoting nutritional care for cancer patients, which is also expected to contribute to the market growth in the region. According to the report published by the National Cancer Institute, in 2020, 1.8 million new cancer cases were registered in the United States. Such increasing rate of cancer is further expected to drive the demand for clinical nutritional products in the North American countries.

Alternatively, the market in Europe is also anticipated to occupy a significant share in the global clinical nutrition market on account of its proven success in terms of technology development and a high prevalence of cancer in the region. As per the analysis of the European Society for Medical Oncology, 2.7 million new cancer cases were registered in the European Union, with 1.3 million deaths in 2020.

Research Nester
Clinical Nutrition Market Regional
Get more information on this report: Request Free Sample PDF

Companies Dominating the Clinical Nutrition Landscape

    •  Nestlé S.A.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Abbott Laboratories
    • Baxter International Inc.
    • Danone S.A.
    • Perrigo Company plc
    • Mead Johnson & Company, LLC
    • BASF SE
    • The Kraft Heinz Company
    • Victus, Inc.

In the News

  • Danone India has announced the release of Protinex Zero Added Sugar varieties in Vanilla Delight and Tasty Chocolate flavors. By introducing these Zero Added Sugar options, Danone is keeping its promise to the FSSAI's Eat Right Movement, whereby it will cut sugar in its portfolio by 20% by 2020 in an effort to provide Indian consumers with healthier food options. Danone's HFD brand Protinex has a rich history spanning more than 60 years. Danone wants to help as many people as possible achieve health through food, and part of its objective is to solve protein insufficiency among Indian consumers.
  • B. Braun, one of the top producers of pharmaceuticals and medical devices worldwide, and Grifols, a major global manufacturer of medicines derived from plasma and a provider of technologies and services for clinics, hospitals, and compounding centers, announced a global partnership aimed at improving therapy safety and pharmacy production output.

Author Credits:  Radhika Pawar


  • Report ID: 6150
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of clinical nutrition was over USD 40 billion.

The market size for clinical nutrition is projected to cross USD 106.19 billion by the end of 2036 expanding at a CAGR of 7.8% during the forecast period i.e., between 2024-2036.

The major players in the market are Abbott, Pfizer Inc., Bayer AG, Nestle Health Science, Baxter, B. Braun SE, Fresenius SE & Co. KGaA, Grifols, S.A., DSM, and others.

The oral clinical nutrition segment is anticipated to garner a share of 54% during 2024-2036.

The North America clinical nutrition sector is poised to hold 33% share by the end of 2036.
Clinical Nutrition Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample